CREALUXE
Food supplement declared in France, declaration No 2024-5-1072
CREALUXE (IO GENIX) is a food supplement declared in France. Status: retrait du marché annoncé pour le 28 October 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- IO GENIX
- Food business operator placing the product on the market
- AYOLABS
- Status
- Retrait du marché annoncé pour le 28 October 2027
- Form
- Poudre
- Daily dose
- 3,3 g
- Directions for use
- Mélanger 3,3 g (¾ del coupelle doseuse environ) de produit de préférence avec une boisson riche en g
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
- Flavourings
- WATERMELON MOJITO
Declaration 141973, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 28 October 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Monohydrate de créatine | not declared |
Additives
E955, E122, E330
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires ne doivent pas être utilisés comme un substitut à une alimentation variée et équilibrée et un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Garder hors de portée des jeunes enfants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : IO GENIX